knowledge -WSS

knowledge

author：comprehensive 2025-09-28 18:47:41 - browse：9315

Adam's take main illustration — Molly Ferguson/STAT

I am one week away from the launch of my weekly email newsletter! It’s called Adam’s Biotech Scorecard, and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

Do you have a biotech-related question you want me to answer in the newsletter? Send me an email at [email protected].

This week: A preview of Intra-Cellular Therapies’ Phase 3 study in major depressive disorder, and a couple of liver-disease physician perspectives on Rezdiffra, the newly approved treatment for MASH from Madrigal Pharmaceuticals.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： FDA does about

Wikipedia

WSS

Study finds gene variants tied to breast cancer risk in Black women

Investigation reveals sickle cell patients pressured into sterilizations

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

FDA poised to publish guidelines for clinical trial diversity

Obesity now affects over 1 billion people worldwide, study finds

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

focus

knowledge

knowledge

Peter Hotez and the public health issue of online harassment

Biogen joins immunology wave with $1.15 billion acquisition of HI

Affirmative action in medical school literally saved lives

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

The cancer drug shortage isn’t new — and neither are the solutions

RaDonda Vaught to speak at CommonSpirit event on patient safety

State Dept. review finds Biden bears some blame for Afghanistan failures

Clinical trials giant ICON acquires HumanFirst

Medicare proposal to cover medical devices draws a mixed reaction

RSV vaccines may be linked to small increased risk of developing GBS

explore

Biogen joins immunology wave with $1.15 billion acquisition of HI

Cue Health, Covid

How to fix the rural physician shortage in the U.S.

As a primary care physician, here's how I hope to partner with AI

How to address the problem of discarded donor organs

An inside look at PIPEs, biotech's buzzy new financing tool

knowledge

Wikipedia

leisure time

focus